In vitro stem cell assay in head and neck squamous carcinoma. 1980

D E Mattox, and D D Von Hoff

Squamous cell carcinoma of the head and neck was successfully cultured from 33 to 73 specimens (45 percent) using the soft agar technique developed by Hamburger and Salmon. Successful cultures were evenly divided between biopsies of primary tumors and metastases; no growth and contaminated specimens predominantly came from biopsies of primary tumors. Prediction of viability before plating with trypan blue was unreliable. The cloning efficiencies in each histologic grade had a wide range, but the median cloning efficiency was higher for poorly differentiated tumors. Six of 11 patients with cloning efficiencies greater than 0.02 percent were dead of disease within 3 months, whereas only 1 of 16 patients with cloning efficiencies less than 0.02 percent was dead of disease at 3 months (p < 0.01). In vitro chemotherapeutic drug sensitivity testing correctly predicted in vivo resistance in three patients. The in vitro stem cell assay should prove a useful tool for clinical and biologic studies of head and neck cancer.

UI MeSH Term Description Entries
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

D E Mattox, and D D Von Hoff
October 2011, The British journal of oral & maxillofacial surgery,
D E Mattox, and D D Von Hoff
January 2013, Stem cells international,
D E Mattox, and D D Von Hoff
January 2011, Journal of oncology,
D E Mattox, and D D Von Hoff
July 2023, Journal of pharmacy & bioallied sciences,
D E Mattox, and D D Von Hoff
January 2014, Otolaryngologia polska = The Polish otolaryngology,
D E Mattox, and D D Von Hoff
January 2009, Methods in molecular biology (Clifton, N.J.),
D E Mattox, and D D Von Hoff
January 2019, Advances in experimental medicine and biology,
D E Mattox, and D D Von Hoff
January 2004, Archives of otolaryngology--head & neck surgery,
D E Mattox, and D D Von Hoff
September 2000, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology,
Copied contents to your clipboard!